Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma.

Kurokawa, Yukinori; Kawase, Tomono; Takeno, Atsushi; Furukawa, Haruna; Yoshioka, Ryo; Saito, Takuro; Takahashi, Tsuyoshi; Shimokawa, Toshio; Eguchi, Hidetoshi; Doki, Yuichiro

Kurokawa, Yukinori; Kawase, Tomono; Takeno, Atsushi; Furukawa, Haruna; Yoshioka, Ryo; Saito, Takuro; Takahashi, Tsuyoshi; Shimokawa, Toshio; Eguchi, Hidetoshi; Doki, Yuichiro.

Afiliación

Kurokawa Y; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.
Kawase T; Department of Surgery Toyonaka Municipal Hospital Osaka Japan.
Takeno A; Department of Surgery Kansai Rosai Hospital Amagasaki Japan.
Furukawa H; Department of Surgery Osaka Rosai Hospital Osaka Japan.
Yoshioka R; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.
Saito T; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.
Takahashi T; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.
Shimokawa T; Clinical Study Support Center Wakayama Medical University Hospital Wakayama Japan.
Eguchi H; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.
Doki Y; Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan.

Ann Gastroenterol Surg ; 7(2): 247-254, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36998295

Palabras clave

docetaxel, oxaliplatin, and S1; esophagogastric junction tumor; gastroesophageal junction cancer; neoadjuvant treatment; preoperative chemotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Gastroenterol Surg Año: 2023 Tipo del documento: Article